Business · Companies · 1 hr ago
Genexine to raise about 3 billion won through new share issue
Genexine plans to raise about 3 billion won through a new share issue, according to a disclosure filed on Oct.
16, 2026.
The South Korean biotech company is listed on the KOSDAQ market.
It will issue 1,250,500 new common shares at 2,399 won each.
The issue is a third-party allotment, a type of share issue made to selected investors.
Genexine plans to use all the proceeds for operating costs.
The disclosure does not say who will receive the shares or give further details about the company's next steps.
Genexine plans to raise about 3 billion won through a third-party allotment of new shares.
The company disclosed the share issue on October 16, 2026.
It will issue 1,250,500 new common shares at 2,399 won each.
Genexine plans to use the proceeds for operating funds.
- Who
- Genexine, a KOSDAQ-listed company.
- What
- It plans a third-party allotment of new shares worth 2,999,949,500 won.
- When
- The company disclosed the issue on October 16, 2026.
- Where
- Not stated.
- Why
- Genexine plans to use the proceeds for operating funds.
This story does not have two clearly opposing sides.
Genexine disclosed its plan to issue new shares through a third-party allotment.
Maeil Business published its report on the share issue.
- Planned proceeds
- 2,999,949,500 won
- New shares
- 1,250,500 common shares
- Issue price
- 2,399 won per share
- Use of proceeds
- Operating funds
- Shares before issue
- 45,540,545 common shares